Log In
BCIQ
Print this Print this
 

ResponseDX-Tissue of Origin (ResponseDX-Tissue or Origin)

  Manage Alerts
Collapse Summary General Information
Company Cancer Genetics Inc.
DescriptionPCR-based genetic test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationSolid tumors
Indication DetailsDiagnose solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$14.0M

$7.0M

0


 Deals Details
Get a free BioCentury trial today